Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Tunneled	O
dialysis	O
catheter	O
placement	O
Left	O
percutaneous	O
nephrostomy	O
tube	O
placement	O
History	O
of	O
Present	O
Illness:	O
This	O
is	O
an	O
___	O
with	O
a	O
history	O
of	O
T2DM,	O
Afib	O
on	O
warfarin,	O
sick	O
sinus	O
syndrome	O
s/p	O
pacemaker	O
placement,	O
CKD5	O
(not	O
on	O
dialysis),	O
who	O
presents	O
as	O
a	O
transfer	O
from	O
___	O
for	O
SOB.	O
She	O
developed	O
SOB	O
on	O
___	O
at	O
___,	O
requiring	O
5L	O
O2,	O
So	O
she	O
was	O
sent	O
to	O
___.	O
At	O
___,	O
she	O
was	O
given	O
80	O
mg	O
IV	O
Lasix,	O
azithromycin	O
500	O
mg	O
IV,	O
ceftriaxone	O
1	O
g	O
IV.	O
A	O
chest	O
x-ray	O
was	O
completed,	O
which	O
showed	O
volume	O
overload,	O
unable	O
to	O
exclude	O
pneumonia.	B-Lower_respiratory_tract_infection
Given	O
that	O
the	O
patient	O
was	O
seen	O
by	O
___	O
nephrology,	O
and	O
dialysis	O
discussion	O
was	O
brought	O
up	O
at	O
outpatient	O
visits,	O
the	O
patient	O
was	O
transferred	O
to	O
___	O
for	O
possible	O
initiation	O
of	O
dialysis.	O
___	O
notes,	O
BNP	O
was	O
62K,	O
creatinine	O
3.2	O
(from	O
2.4),	O
and	O
INR	O
supratherapeutic	O
at	O
3.8.	O
On	O
evaluation	O
in	O
the	O
___,	O
the	O
patient	O
states	O
that	O
she	O
is	O
not	O
short	O
of	O
breath.	O
When	O
asked	O
if	O
she	O
is	O
having	O
trouble	O
breathing,	O
she	O
responds,	O
"I	O
am	O
breathing	O
fine.	O
Why	O
does	O
everyone	O
keep	O
asking	O
me	O
that?"	O
She	O
denies	O
dysuria,	O
fevers,	O
chills,	O
chest	O
pain,	O
diarrhea.	O
Vital	O
signs	O
notable	O
for	O
temp	O
97.6,	O
heart	O
rate	O
97,	O
blood	O
pressure	O
162/79,	O
respiratory	O
rate	O
22,	O
pulse	O
ox	O
93%	O
on	O
2	O
L	O
nasal	O
cannula	O
Labs	O
notable	O
for	O
CBC	O
with	O
a	O
hemoglobin	O
of	O
8,	O
white	O
blood	O
cell	O
count	O
10.8,	O
BUN	O
52,	O
creatinine	O
3.3,	O
anion	O
gap	O
20,	O
lactate	O
1.3,	O
troponin	O
0.09,	O
BNP	O
63,861,	O
UA	O
with	O
large	O
leukoesterase,	O
moderate	O
blood,	O
negative	O
nitrate,	O
75	O
WBCs,	O
few	O
bacteria	O
Rectal	O
guaiac	O
neg.	O
She	O
reports	O
that	O
the	O
year	O
is	O
___.	O
She	O
cannot	B-Delirium
remember	B-Delirium
the	O
president.	O
She	O
was	O
states	O
that	O
we	O
are	O
in	O
___.	O
Regarding	O
her	O
___	O
on	O
CKD,	O
she	O
was	O
recently	O
hospitalized	O
at	O
___.	O
She	O
was	O
found	O
to	O
have	O
an	O
obstructive	O
uropathy	O
and	O
an	O
___.	O
She	O
eventually	O
underwent	O
cystoscopy,	O
and	O
left-sided	O
stent	O
placement	O
at	O
the	O
end	O
of	O
___.	O
Even	O
after	O
this	O
procedure,	O
her	O
creatinine	O
worsened,	O
and	O
it	O
is	O
around	O
the	O
2.8	O
range.	O
Patient	O
is	O
DNR/DNI	O
per	O
medical	O
records	O
from	O
___	O
confirmed	O
in	O
MOLST	O
in	O
paperwork	O
from	O
Nursing	B-Lives_in_carehome
Home.	B-Lives_in_carehome
Per	O
the	O
records	O
that	O
came	O
with	O
her	O
from	O
her	O
nursing	B-Lives_in_carehome
home,	B-Lives_in_carehome
she	O
was	O
treated	O
for	O
C.	O
difficile,	O
or	O
is	O
currently	O
being	O
treated	O
for	O
C.	O
difficile.	O
However,	O
in	O
her	O
active	O
medication	O
list,	O
vancomycin	O
is	O
not	O
listed.	O
Contact	O
was	O
attempted	O
overnight	O
to	O
the	O
nursing	B-Lives_in_carehome
home	B-Lives_in_carehome
to	O
clarify,	O
but	O
no	O
one	O
picked	O
up	O
the	O
phone.	O
CXR	O
at	O
___	O
Bilateral	O
perihilar	O
opacities,	O
slightlyincreased	O
on	O
the	O
left	O
and	O
slightly	O
improvedon	O
the	O
right,	O
which	O
may	O
reflect	O
pneumonia	B-Lower_respiratory_tract_infection
versus	O
edema.	O
CXR	O
at	O
___	O
Pulmonary	O
edema.	O
Persistent	O
bibasilar	O
opacities	O
likely	O
components	O
of	O
pleural	O
effusions	O
and	O
atelectasis	O
noting	O
that	O
infection	O
cannot	O
be	O
entirely	O
excluded.	O
EKG:	O
rate	O
68,	O
V-paced	O
Past	O
Medical	O
History:	O
Stage	O
V	O
CKD	O
secondary	O
to	O
underlying	O
hypertensive	O
nephrosclerosis	O
Hypertension	O
H/o	O
Cdiff	O
T2DM	O
Gout	O
Atrial	O
Fibrillation	O
on	O
warfarin	O
SSS,	O
s/p	O
___	O
dual-chamber	O
pacemaker	O
Hypercholesterolemia	O
Chronic	O
diastolic	O
heart	O
failure	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
cancer,	O
per	O
patient	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
VS:98.6PO	O
169	O
/	O
79L	O
Lying	O
65	O
19	O
95	O
3L	O
GENERAL:	O
Elderly	O
appearing	O
female	O
in	O
no	O
acute	O
distress,	O
knows	O
the	O
year,	O
states	O
she	O
is	O
in	O
need	O
him,	O
cannot	B-Unspecified_cognitive_impairment
remember	B-Unspecified_cognitive_impairment
the	O
president.	O
HEENT:	O
AT/NC,	O
anicteric	O
sclera,	O
MMM	O
NECK:	O
supple,	O
no	O
LAD	O
CV:	O
RRR,	O
S1/S2,	O
2	O
out	O
of	O
6	O
crescendo	O
decrescendo	O
murmur	O
best	O
auscultated	O
at	O
the	O
base	O
of	O
the	O
heart	O
PULM:	O
Mild	O
crackles	O
in	O
the	O
lower	O
lung	O
fields	O
bilaterally	O
GI:	O
abdomen	O
soft,	O
nondistended,	O
nontender	O
in	O
all	O
quadrants,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
no	O
cyanosis,	O
clubbing,	O
or	O
edema	O
PULSES:	O
2+	O
radial	O
pulses	O
bilaterally	O
NEURO:	O
Alert,	O
moving	O
all	O
4	O
extremities	O
with	O
purpose,	O
face	O
symmetric	O
DERM:	O
Bruise	O
on	O
the	O
left	O
anterior	O
chest	O
wall	O
around	O
the	O
pacemaker	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
GENERAL:	O
Chronically	O
ill-appearing,	O
very	O
pleasant,	O
lying	O
in	O
bed,	O
eyes	O
closed,	O
in	O
NAD	O
HEENT:	O
NC/AT,	O
anicteric	O
sclera,	O
MMM	O
CV:	O
RRR,	O
normal	O
S1	O
with	O
loss	O
of	O
S2,	O
harsh	O
IV/VI	O
systolic	O
murmur	O
loudest	O
at	O
RUSB	O
PULM:	O
Decreased	O
breath	O
sounds	O
in	O
bases,	O
no	O
wheezes	O
or	O
crackles	O
GI:	O
Soft,	O
non-tender,	O
non-distended	O
EXTREMITIES:	O
No	O
cyanosis,	O
clubbing,	O
or	O
edema.	O
R	O
knee	O
enlarged	O
but	O
neither	O
warm	O
nor	O
erythematous,	O
no	O
appreciable	O
edema	O
or	O
effusion	O
SKIN:	O
Warm,	O
well-perfused,	O
no	O
rashes	O
NEURO:	O
Alert,	O
conversant,	O
no	O
gross	O
focal	O
deficits	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
10:01PM	O
BLOOD	O
WBC-10.8*	O
RBC-2.38*	O
Hgb-8.0*	O
Hct-26.4*	O
MCV-111*	O
MCH-33.6*	O
MCHC-30.3*	O
RDW-14.5	O
RDWSD-58.1*	O
Plt	O
___	O
___	O
10:01PM	O
BLOOD	O
Neuts-77.0*	O
Lymphs-10.3*	O
Monos-7.8	O
Eos-3.8	O
Baso-0.3	O
Im	O
___	O
AbsNeut-8.34*	O
AbsLymp-1.12*	O
AbsMono-0.85*	O
AbsEos-0.41	O
AbsBaso-0.03	O
___	O
06:40AM	O
BLOOD	O
___	O
___	O
10:01PM	O
BLOOD	O
Glucose-153*	O
UreaN-52*	O
Creat-3.3*	O
Na-145	O
K-4.4	O
Cl-108	O
HCO3-17*	O
AnGap-20*	O
___	O
10:01PM	O
BLOOD	O
CK(CPK)-19*	O
___	O
06:40AM	O
BLOOD	O
Calcium-9.7	O
Phos-4.5	O
Mg-2.2	O
Iron-31	O
DISCHARGE	O
LABS	O
___	O
12:08PM	O
BLOOD	O
WBC-10.4*	O
RBC-2.47*	O
Hgb-8.1*	O
Hct-25.6*	O
MCV-104*	O
MCH-32.8*	O
MCHC-31.6*	O
RDW-16.7*	O
RDWSD-63.4*	O
Plt	O
___	O
___	O
07:39AM	O
BLOOD	O
Neuts-71.7*	O
Lymphs-14.2*	O
Monos-9.3	O
Eos-3.2	O
Baso-0.6	O
Im	O
___	O
AbsNeut-7.72*	O
AbsLymp-1.53	O
AbsMono-1.00*	O
AbsEos-0.34	O
AbsBaso-0.06	O
___	O
12:08PM	O
BLOOD	O
___	O
PTT-34.0	O
___	O
___	O
12:08PM	O
BLOOD	O
Glucose-253*	O
UreaN-40*	O
Creat-3.4*	O
Na-138	O
K-3.4*	O
Cl-97	O
HCO3-28	O
AnGap-13	O
___	O
12:08PM	O
BLOOD	O
Calcium-10.4*	O
Phos-3.6	O
Mg-2.2	O
OTHER	O
PERTINENT	O
LABS	O
___	O
06:40AM	O
BLOOD	O
calTIBC-165*	O
Ferritn-1150*	O
TRF-127*	O
___	O
10:01PM	O
BLOOD	O
VitB12-287	O
Folate-10	O
MICRO	O
___	O
10:02	O
pm	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
No	O
growth	O
to	O
date.	O
___	O
9:48	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
IMAGING/STUDIES	O
___	O
Transthoracic	O
Echo	O
Report	O
CONCLUSION:	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
moderately	O
increased.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
suboptimal	O
image	O
quality	O
to	O
assess	O
regional	O
left	O
ventricular	O
function.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
secondary	O
to	O
pacinginduced	O
dyssynchrony.	O
The	O
visually	O
estimated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
45%.	O
There	O
is	O
no	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
There	O
is	O
Grade	O
III	O
diastolic	O
dysfunction.	O
The	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
depressed	O
free	O
wall	O
motion.	O
The	O
aortic	O
sinus	O
is	O
mildly	O
dilated	O
with	O
mildly	O
dilated	O
ascending	O
aorta.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened.	O
There	O
is	O
SEVERE	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
less	O
than	O
1.0	O
cm2).	O
There	O
is	O
trace	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
moderate	O
mitral	O
annular	O
calcification.	O
There	O
is	O
no	O
mitral	O
valve	O
stenosis.	O
There	O
is	O
mild	O
[1+]	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
moderate	O
[2+]	O
tricuspid	O
regurgitation.	O
There	O
is	O
moderate	O
to	O
severe	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
A	O
left	O
pleural	O
effusion	O
is	O
present.	O
Compared	O
with	O
the	O
prior	O
TTE	O
___,	O
severe	O
aortic	O
stenosis	O
is	O
now	O
present.	O
___	O
CHEST	O
(PA	O
&	O
LAT)	O
IMPRESSION:	O
Pulmonary	O
edema.	O
Persistent	O
bibasilar	O
opacities	O
likely	O
components	O
of	O
pleural	O
effusions	O
and	O
atelectasis	O
noting	O
that	O
infection	O
cannot	O
be	O
entirely	O
excluded.	O
___	O
Renal	O
US	O
1.	O
2	O
new	O
left	O
renal	O
calculi	O
associated	O
with	O
moderate	O
to	O
severe	O
hydroureteronephrosis.	O
However,	O
no	O
definite	O
short-term	O
change	O
since	O
the	O
recent	O
prior	O
CT.	O
2.	O
Left	O
nephroureteral	O
stent	O
is	O
seen	O
within	O
a	O
dilated	O
left	O
renal	O
pelvis.	O
3.	O
The	O
right	O
kidney	O
is	O
within	O
normal	O
limits.	O
___	O
Percutaneous	O
nephrostogram	O
1.	O
Mildly	O
dilated	O
left	O
renal	O
calices	O
with	O
a	O
dilated	O
extrarenal	O
pelvis	O
containing	O
a	O
double-J	O
stent.	O
2.	O
Nephrostomy	O
tube	O
curled	O
in	O
the	O
renal	O
pelvis.	O
Final	O
image	O
demonstrates	O
aspiration	O
of	O
the	O
contrast	O
and	O
contents	O
of	O
the	O
renal	O
pelvis.	O
3.	O
Limited	O
contrast	O
nephrostogram	O
indicates	O
that	O
the	O
ureter	O
is	O
likely	O
patient.	O
There	O
is	O
drainage	O
of	O
the	O
contrast	O
from	O
the	O
ureter	O
over	O
time.	O
___	O
Video	O
oropharyngeal	O
swallow	O
study	O
Penetration	O
and	O
aspiration	O
with	O
both	O
liquids	O
and	O
solids,	O
likely	O
secondary	O
to	O
delayed	O
swallow	O
reduced	O
laryngeal	O
vestibule	O
closure.	O
Please	O
note	O
that	O
a	O
detailed	O
description	O
of	O
dynamic	O
swallowing	O
as	O
well	O
as	O
a	O
summative	O
assessment	O
and	O
recommendations	O
are	O
reported	O
separately	O
in	O
a	O
standalone	O
note	O
by	O
the	O
Speech-Language	O
Pathologist	O
(OMR,	O
Notes,	O
Rehabilitation	O
Services).	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
with	O
a	O
history	O
of	O
HFpEF,	O
Afib	O
on	O
warfarin,	O
sick	O
sinus	O
syndrome	O
s/p	O
pacemaker	O
placement,	O
and	O
CKD5	O
(not	O
previously	O
on	O
dialysis),	O
who	O
initially	O
presented	O
as	O
a	O
transfer	O
from	O
___	O
with	O
acute	O
on	O
chronic	O
HFpEF	O
exacerbation,	O
found	O
to	O
have	O
new	O
severe	O
AS,	O
course	O
c/b	O
___	O
on	O
CKD	O
secondary	O
to	O
cardiorenal	O
syndrome.	O
ACTIVE	O
ISSUES:	O
==============	O
#	O
ESRD	O
s/p	O
HD	O
initiation	O
on	O
___	O
#	O
L	O
hydronephrosis/hydroureter	O
Patient	O
presented	O
with	O
___	O
on	O
CKD,	O
which	O
was	O
initially	O
thought	O
to	O
be	O
secondary	O
to	O
cardiorenal	O
syndrome	O
given	O
aortic	O
stenosis	O
with	O
volume	O
overload,	O
vs	O
possible	O
over-diuresis.	O
Incidentally	O
noticed	O
left-sided	O
hydronephrosis	O
on	O
a	O
CT	O
scan	O
of	O
the	O
chest,	O
so	O
urology	O
was	O
consulted	O
and	O
felt	O
that	O
ureteral	O
tube	O
was	O
likely	O
functioning	O
well	O
and	O
did	O
not	O
need	O
replacement.	O
Renal	O
function	O
continued	O
to	O
decline	O
and	O
patient	O
became	O
encephalopathic	O
requiring	O
urgent	O
HD	O
initiation	O
with	O
improvement	O
in	O
mental	O
status.	O
PCN	O
tube	O
placement	O
was	O
initially	O
deferred	O
due	O
to	O
concern	O
that	O
renal	O
dysfunction	O
was	O
irreversible;	O
however,	O
underwent	O
L	O
PCN	O
with	O
___	O
on	O
___.	O
Despite	O
decompression	O
with	O
PCN,	O
patient	O
was	O
still	O
anuric	O
and	O
PCN	O
with	O
minimal	O
output,	O
therefore	O
it	O
was	O
capped.	O
Monitored	O
for	O
fever,	O
flank	O
pain,	O
and	O
leakage	O
around	O
the	O
tube.	O
Continued	O
sevelamer	O
800mg	O
TID	O
with	O
meals.	O
Bicarb	O
was	O
discontinued	O
after	O
starting	O
HD.	O
#	O
Acute	O
on	O
chronic	O
diastolic	O
heart	O
failure	O
exacerbation	O
#	O
Aortic	O
Stenosis	O
Initially	O
presented	O
with	O
hypoxemia	O
and	O
volume	O
overload	O
consistent	O
with	O
acute	O
HFpEF	O
exacerbation.	O
Received	O
IV	O
diuresis	O
with	O
some	O
resolution	O
of	O
hypoxemia	O
and	O
improvement	O
in	O
volume	O
status;	O
however,	O
patient	O
had	O
progressively	O
declining	O
renal	O
function	O
concerning	O
for	O
overdiuresis.	O
TTE	O
on	O
___	O
showed	O
progression	O
of	O
aortic	O
stenosis	O
to	O
severe	O
from	O
moderate	O
on	O
prior.	O
Rapid	O
progression	O
of	O
aortic	O
stenosis	O
likely	O
due	O
to	O
calcification	O
iso	O
renal	O
failure.	O
Continued	O
metoprolol	O
tartrate	O
25mg	O
PO	O
Q6H.	O
Home	O
hydralazine	O
PO	O
increased	O
from	O
50	O
to	O
75	O
mg	O
TID	O
for	O
greater	O
afterload	O
reduction.	O
Cardiology	O
was	O
consulted	O
given	O
need	O
for	O
HD	O
with	O
likely	O
preload-dependent	O
AS.	O
They	O
felt	O
that	O
risks	O
of	O
TAVR	O
or	O
balloon	O
angioplasty	O
outweighed	O
any	O
possible	O
benefit.	O
She	O
was	O
able	O
to	O
tolerate	O
HD	O
without	O
hypotension.	O
BPs	O
stable	O
in	O
150s-160s/60s	O
(allowing	O
some	O
permissive	O
hypertension	O
to	O
avoid	O
dropping	O
diastolic	O
blood	O
pressure	O
and	O
to	O
maintain	O
preload).	O
Tentative	O
plan	O
to	O
pursue	O
further	O
evaluation	O
by	O
TAVR	O
team	O
as	O
outpatient,	O
although	O
unlikely	O
that	O
she	O
would	O
be	O
a	O
candidate	O
for	O
this	O
procedure	O
given	O
comorbidities.	O
#CAUTI	O
-	O
resolved	O
New	O
leukocytosis	O
16.8	O
on	O
___.	O
Patient	O
lethargic	O
but	O
arousable	O
and	O
hemodynamically	O
stable.	O
UCx	O
from	O
___	O
grew	O
E	O
coli	O
sensitive	O
to	O
CTX.	O
Foley	O
was	O
removed	O
and	O
patient	O
was	O
given	O
ceftriaxone	O
(___	O
with	O
improvement	O
in	O
mental	O
status.	O
#	O
Toxic	O
metabolic	O
encephalopathy	B-Delirium
#	O
Delirium	B-Delirium
Intermittent	O
episodes	O
of	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
that	O
resolved	O
after	O
initiation	O
of	O
HD	O
and	O
treatment	O
of	O
UTI.	B-Urinary_tract_infection
Initially	O
felt	O
___	O
uremia	O
and	O
hypernatremia,	O
but	O
fluctuating	O
mental	B-Delirium
status	B-Delirium
continued	O
despite	O
initiation	O
of	O
HD	O
and	O
normalization	O
of	O
sodium.	O
S/p	O
CT	O
head	B-Intracranial_haemorrhage
___	O
that	O
was	O
negative	O
for	O
ICH,	B-Intracranial_haemorrhage
edema,	O
and	O
mass	O
lesion.	O
Mental	O
status	O
stabilized	O
prior	O
to	O
discharge.	O
#	O
Malnutrition	B-Malnutrition
#	O
Dysphagia	O
#	O
Hypernatremia	O
Poor	O
PO	O
intake	O
and	O
hypoalbuminemia	O
suggesting	O
malnutrition.	B-Malnutrition
Evaluated	O
by	O
S&S	O
who	O
noted	O
some	O
difficulty	O
with	O
thin	O
liquids	O
and	O
solids.	O
Nutrition	O
and	O
speech/swallow	O
were	O
consulted.	O
Video	O
swallow	O
evaluation	O
showed	O
silent	O
aspiration;	O
however,	O
after	O
discussion	O
with	O
son/HCP,	O
it	O
was	O
deemed	O
more	O
within	O
___	O
to	O
allow	O
patient	O
to	O
continue	O
to	O
eat	O
for	O
comfort.	O
Encouraged	O
PO	O
free-water	O
intake	O
for	O
hypernatremia.	O
#	O
___	O
Patient	O
has	O
been	O
persistently/intermittently	O
encephalopathic	B-Delirium
throughout	O
her	O
prolonged	O
hospital	O
course.	O
She	O
will	O
be	O
discharged	O
to	O
a	O
facility	O
with	O
lifelong	O
dependence	O
on	O
hemodialysis.	O
She	O
is	O
also	O
having	O
some	O
dysphagia	O
requiring	O
diet	O
modification.	O
However,	O
her	O
mental	O
status	O
has	O
shown	O
considerable	O
improvement	O
with	O
initiation	O
of	O
hemodialysis	O
and	O
treatment	O
of	O
UTI.	B-Urinary_tract_infection
Patient	O
silently	O
aspirating	O
by	O
video-swallow	O
eval,	O
but	O
allowed	O
to	O
eat	O
for	O
comfort	O
despite	O
aspiration	O
risk	O
after	O
discussion	O
with	O
HCP.	O
#	O
Atrial	O
fibrillation	O
CHADS2-VASc	O
6.	O
Warfarin	O
intermittently	O
held	O
for	O
procedures	O
(tunneled	O
HD	O
catheter,	O
PCN	O
tube).	O
INR	O
was	O
highly	O
variable,	O
likely	O
iso	O
poor	B-Malnutrition
nutrition	B-Malnutrition
and	O
dose	O
of	O
levofloxacin	O
earlier	O
in	O
course.	O
Restarted	O
prior	O
to	O
discharge.	O
Continued	O
metoprolol	O
tartrate	O
25mg	O
q6hrs,	O
consolidated	O
to	O
metoprolol	O
succinate	O
200	O
mg	O
daily	O
for	O
home	O
dosing.	O
CHRONIC	O
ISSUES	O
================	O
#	O
Hypertension	O
Continued	O
home	O
amlodipine	O
10mg	O
daily	O
and	O
increased	O
hydralazine	O
to	O
75mg	O
TID	O
#	O
Type	O
2	O
diabetes	O
Stopped	O
glipizide	O
permanently	O
given	O
ESRD.	O
Insulin	O
sliding	O
scale	O
initially	O
while	O
inpatient,	O
but	O
later	O
stopped	O
with	O
BGs	O
in	O
100s-200s,	O
therefore	O
not	O
discharge	O
insulin	O
not	O
continued.	O
#	O
Gout	O
Continued	O
home	O
allopurinol	O
___	O
every	O
other	O
day,	O
dosed	O
renally.	O
#	O
Hyperlipidemia	O
Continued	O
home	O
atorvastatin	O
10mg	O
qpm.	O
#	O
GERD	O
Continued	O
home	O
Zantac	O
150mg	O
daily	O
#CODE:	O
DNR/DNI	O
(confirmed)	O
#CONTACT/HCP:	O
___	O
Relationship:	O
Son/HCP	O
Phone:	O
___	O
___	O
issues	O
=============	O
Discharge	O
creatinine	O
3.4	O
Discharge	O
weight	O
58.2	O
Kg	O
Discharge	O
hemoglobin	O
8.1	O
Discharge	O
INR	O
2.5	O
Discharge	O
WBC:	O
10.4	O
[	O
]	O
Please	O
recheck	O
CBC	O
on	O
___	O
to	O
make	O
sure	O
WBC	O
is	O
not	O
worsening.	O
It	O
was	O
10.4	O
on	O
discharge.	O
[	O
]	O
Please	O
continue	O
to	O
check	O
HD	O
line	O
site	O
as	O
it	O
has	O
looked	O
red,	O
but	O
has	O
been	O
improving.	O
(Outlined	O
with	O
marker.)	O
[	O
]	O
If	O
patient	O
unable	O
to	O
tolerate	O
HD,	O
may	O
be	O
in	O
the	O
setting	O
of	O
severe	O
aortic	O
stenosis	O
--	O
could	O
consider	O
discussing	O
balloon	O
valvuloplasty	O
vs.	O
TAVR,	O
if	O
within	O
goals	O
of	O
care.	O
Deferred	O
during	O
this	O
hospitalization	O
because	O
patient	O
was	O
hemodynamically	O
stable	O
with	O
hemodialysis	O
and	O
the	O
risks	O
of	O
the	O
procedure	O
were	O
felt	O
to	O
outweigh	O
any	O
possible	O
benefit.	O
[	O
]	O
Given	O
macrocytic	O
anemia	O
and	O
high	O
ferritin,	O
patient	O
was	O
started	O
on	O
B12	O
supplementation	O
and	O
taken	O
off	O
iron	O
supplementation.	O
Iron	O
studies	O
and	O
B12	O
level	O
should	O
be	O
followed	O
up	O
as	O
outpatient.	O
[	O
]	O
Found	O
to	O
have	O
incidental	O
19	O
x	O
16	O
mm	O
cyst	O
pancreatic	O
cysts	O
on	O
CT	O
abdomen	O
and	O
pelvis.	O
For	O
pancreatic	O
cysts	O
measuring	O
more	O
than	O
1.5cm,	O
patients	O
should	O
be	O
referred	O
to	O
the	O
pancreas	O
cyst	O
clinic	O
for	O
consultation.	O
These	O
referrals	O
can	O
be	O
made	O
by	O
emailing	O
___	O
or	O
by	O
calling	O
___.	O
[	O
]	O
Please	O
ensure	O
follow	O
up	O
with	O
interventional	O
radiology	O
for	O
removal	O
of	O
percutaneous	O
nephrostomy	O
tubes	O
___	O
weeks	O
post-discharge	O
and	O
with	O
urology	O
for	O
left	O
ureteral	O
stent	O
removal.	O
She	O
needs	O
follow-up	O
with	O
Dr.	O
___	O
in	O
___	O
for	O
management	O
of	O
left	O
ureteral	O
stent.	O
[	O
]	O
Please	O
monitor	O
output	O
from	O
PCN	O
q6hrs	O
and	O
monitor	O
PCN	O
for	O
signs	O
of	O
leakage	O
or	O
flank	O
pain.	O
[	O
]	O
Has	O
known	O
moderate-sized,	O
bilateral	O
pleural	O
effusions.	O
If	O
imaging	O
is	O
obtained,	O
be	O
aware	O
that	O
these	O
effusions	O
are	O
chronic	O
in	O
nature,	O
and	O
that	O
volume	O
status	O
is	O
now	O
being	O
managed	O
through	O
hemodialysis	O
sessions	O
as	O
patient	O
is	O
oliguric.	O
#CODE:	O
DNR/DNI	O
(confirmed)	O
#CONTACT/HCP:	O
Son	O
is	O
HCP	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
2.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
3.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
BID	O
4.	O
GlipiZIDE	O
5	O
mg	O
PO	O
BID	O
5.	O
melatonin	O
3	O
mg	O
oral	O
QHS	O
6.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
BID	O
7.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
8.	O
Senna	O
17.2	O
mg	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
9.	O
Vitamin	O
D	O
400	O
UNIT	O
PO	O
DAILY	O
10.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
11.	O
TraMADol	O
50	O
mg	O
PO	O
QHS	O
12.	O
HydrALAZINE	O
50	O
mg	O
PO	O
TID	O
13.	O
Salonpas	O
(methyl	O
salicylate-menthol)	O
___	O
%	O
topical	O
BID	O
14.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
15.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
16.	O
Sodium	O
Bicarbonate	O
650	O
mg	O
PO	O
BID	O
17.	O
Levofloxacin	O
500	O
mg	O
PO	O
Q24H	O
18.	O
Ipratropium-Albuterol	O
Neb	O
1	O
NEB	O
NEB	O
Q6H	O
19.	O
TraMADol	O
50	O
mg	O
PO	O
BID:PRN	O
Pain	O
-	O
Moderate	O
20.	O
Acetaminophen	O
___	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild/Fever	O
Discharge	O
Medications:	O
1.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QPM	O
Apply	O
daily	O
to	O
right	O
knee.	O
RX	O
*lidocaine	O
[Aspercreme	O
(lidocaine)]	O
4	O
%	O
daily	O
Disp	O
#*14	O
Patch	O
Refills:*0	O
2.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
3.	O
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
4.	O
sevelamer	O
CARBONATE	O
800	O
mg	O
PO	O
TID	O
W/MEALS	O
5.	O
Warfarin	O
1	O
mg	O
PO	O
DAILY16	O
a-fib	O
Please	O
adjust	O
as	O
necessary	O
for	O
INR	O
___.	O
6.	O
Allopurinol	O
___	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
7.	O
HydrALAZINE	O
75	O
mg	O
PO	O
Q8H	O
8.	O
Acetaminophen	O
___	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild/Fever	O
9.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
10.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
11.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
DAILY	O
12.	O
Ipratropium-Albuterol	O
Neb	O
1	O
NEB	O
NEB	O
Q6H	O
13.	O
melatonin	O
3	O
mg	O
oral	O
QHS	O
14.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
15.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
16.	O
Salonpas	O
(methyl	O
salicylate-menthol)	O
___	O
%	O
topical	O
BID	O
17.	O
Senna	O
17.2	O
mg	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
18.	O
Vitamin	O
D	O
400	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
diagnosis:	O
=============	O
Acute	O
on	O
chronic	O
diastolic	O
heart	O
failure	O
Severe	O
aortic	O
stenosis	O
Acute	O
hypoxic	O
respiratory	O
failure	O
End	O
stage	O
renal	O
disease	O
Atrial	O
fibrillation	O
Warfarin	O
Urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
Hematuria	O
Acute	O
kidney	O
injury	O
on	O
chronic	O
kidney	O
disease	O
Macrocytic	O
anemia	O
Secondary	O
diagnoses:	O
================	O
Type	O
2	O
diabetes	O
Gout	O
Hypertension	O
Hyperlipidemia	O
Gastroesophageal	O
reflux	O
disease	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	B-Mobile_with_assistance
chair	B-Mobile_with_assistance
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
you	O
are	O
short	O
of	O
breath	O
and	O
had	O
a	O
low	O
oxygen	O
level	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
You	O
were	O
found	O
to	O
have	O
fluid	O
in	O
your	O
lungs,	O
and	O
were	O
given	O
a	O
water	O
pill	O
to	O
remove	O
the	O
fluid.	O
-Your	O
kidney	O
function	O
declined,	O
so	O
you	O
were	O
started	O
on	O
dialysis.	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-Please	O
call	O
to	O
schedule	O
interventional	O
radiology	O
appointment	O
for	O
percutaneous	O
nephrostomy	O
tube	O
removal	O
___	O
weeks	O
after	O
discharge:	O
___	O
-Please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
and	O
follow-up	O
with	O
your	O
appointments	O
as	O
listed	O
below.	O
Please	O
weigh	O
yourself	O
every	O
day	O
and	O
call	O
your	O
PCP	O
if	O
your	O
weight	O
goes	O
up	O
by	O
more	O
than	O
3	O
pounds.	O
-Monitor	O
for	O
signs	O
of	O
infection	O
around	O
your	O
kidney	O
tube	O
(redness,	O
warmth,	O
pus,	O
or	O
pain	O
in	O
your	O
side).	O
Call	O
your	O
doctor	O
if	O
you	O
notice	O
any	O
of	O
these.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

